OFFICIAL PUBLICATION OF

by its subsidiary APPco

UTI prescribing and risk

24/07/2020

PDL says it has flagged some risk considerations for pharmacists participating in the Queensland UTI trial In an update for Queensland members, PDL outlines a number of issues relating to the trial. The UTIPP-Q is a research pilot program aimed at investigating the supply of specified antibiotics, without a prescription, by pharmacists working in Queensland

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

UTI prescribing and risk

Previous Clinical tips: COVID-19

Next Winning student named

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Clinical tips: COVID-19

Next Winning student named

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.